Longitudinal Trajectories of CKD-Associated Pruritus
CKD-aP is a prevalent and fluctuating symptom in patients on HD. Its association with poorer fatigue and sleep outcomes highlights the importance of ongoing monitoring and targeted management to improve patient well-being.
Authors
- Thilo Schaufler (ORCID: https://orcid.org/0000-0003-1886-829X)
- James Fotheringham (ORCID: https://orcid.org/0000-0002-8980-2223)
- Marc Vervloet (ORCID: https://orcid.org/0000-0003-4607-9415)
- Angelo Karaboyas (ORCID: https://orcid.org/0000-0001-8846-5360)
- Sammantha Fuller
- Despina Ruessmann
- Ronald L. Pisoni
- Roberto Pecoits-Filho
- Charlotte Tu
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- Vifor Pharma (Switzerland) (CH)
- Arbor Research Collaborative for Health (US)
- University of Sheffield (GB)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1016/j.ekir.2025.10.023
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- AstraZeneca
- Fresenius Medical Care North America
- Nierstichting
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Novo Nordisk
- Akebia Therapeutics